Gaarslev K, Stenderup J
Curr Med Res Opin. 1985;9(6):384-7. doi: 10.1185/03007998509109608.
A randomized double-blind study was carried out in a group of Danish students visiting Mexico for 2 weeks to investigate the efficacy of mecillinam when given orally in preventing travellers' diarrhoea. The subjects took either 200 mg mecillinam daily as a single dose or placebo for 14 days. Nine (56%) out of 16 taking placebo and 3 (19%) out of 16 taking mecillinam developed travellers' diarrhoea (p less than 0.05). The pathogenic aetiology was not ascertained. A complete change in the Enterobacteriaceae flora took place during travel. A highly antibiotic-resistant Enterobacteriaceae flora was acquired in Mexico in subjects on mecillinam prophylaxis as well as on placebo. Selection of mecillinam-resistant bacteria was minimal.
一项随机双盲研究在一组前往墨西哥访问两周的丹麦学生中开展,以调查口服美西林预防旅行者腹泻的疗效。受试者连续14天每日服用200毫克美西林单剂量或安慰剂。服用安慰剂的16人中有9人(56%)发生旅行者腹泻,服用美西林的16人中有3人(19%)发生旅行者腹泻(p<0.05)。致病病因未明确。旅行期间肠杆菌科菌群发生了彻底变化。接受美西林预防和安慰剂预防的受试者在墨西哥均获得了高度耐药的肠杆菌科菌群。对美西林耐药细菌的选择极少。